Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aurinia Pharmaceuticals Inc. logo — company profile

Aurinia Pharmaceuticals Inc.

Founded 2013 Canada Edmonton, Canada 256 employees Post Ipo Equity Total: $658.63M Biopharma, Biotechnology +2

General Information

Company Name Aurinia Pharmaceuticals Inc.
Founded Year 2013
Location Canada Edmonton, Canada +3
Employees 256
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Post Ipo Equity
Social

Get notified when Aurinia Pharmaceuticals Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. is a Canadian biopharmaceutical company founded in 2011. The company is focused on addressing autoimmune diseases through innovative scientific research. Aurinia recently received a major investment of $200.00M in post-IPO equity funding on 22 July 2020. This significant investment demonstrates the confidence of the investor community in Aurinia's potential to make a meaningful impact in the biopharma, biotechnology, and healthcare industries. With a commitment to rigorous science and breakthrough treatments, Aurinia is well-positioned to drive advancements in addressing some of the most challenging autoimmune diseases. For more information, visit their website.

Taxonomy: autoimmune disease, medical science, pharmaceuticals, community guidelines, public engagement, patient education, scientific research, health information, regulatory compliance, online community management

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 22 Jul 2020
Post-IPO Equity •••••• - 12 Dec 2019
Post-IPO Equity •••••• - 20 Mar 2017
Post-IPO Equity •••••• - 28 Dec 2016
Post-IPO Equity •••••• - 15 Jun 2016

View All 7 Funding Rounds

Aurinia Pharmaceuticals Inc. Alternatives & Competitors

Aurinia Pharmaceuticals Inc. vs
Fresno Unified School District
Fresno Unified School District United States

Achieving Our Greatest Potential!

Grant
4276 employees
EdTech, Education
Compare Aurinia Pharmaceuticals Inc. vs Fresno Unified School District
Aurinia Pharmaceuticals Inc. vs
First State Bank of St. Charles
First State Bank of St. Charles United States

Independent & Locally-Owned Since 1867

171 employees
Crypto, Financial Services
Compare Aurinia Pharmaceuticals Inc. vs First State Bank of St. Charles
Aurinia Pharmaceuticals Inc. vs
Ninth Circuit Court of Florida
Ninth Circuit Court of Florida United States

Justice in Florida shall be accessible, fair, effective, responsive, and accountable.

108 employees
Government and Military, Legal Tech
Compare Aurinia Pharmaceuticals Inc. vs Ninth Circuit Court of Florida
Also compare with: Aurinia Pharmaceuticals Inc. vs Engility Corporation Formerly TASC Engility Corporation Formerly TASC

FAQ About Aurinia Pharmaceuticals Inc.

We pursue promising science to address some of the toughest challenges in autoimmune disease. Community guidelines: 1. By posting to our social media channels, or otherwise responding or commenting on our posts, you are agreeing to abide by these guidelines, which apply in addition to any terms a...
Aurinia Pharmaceuticals Inc. was founded in 2013.
Aurinia Pharmaceuticals Inc. is headquartered in Edmonton, Canada.
Aurinia Pharmaceuticals Inc. operates in the following industries: Biopharma, Biotechnology, Health Care, Health and Wellness.
Aurinia Pharmaceuticals Inc. has approximately 256 employees.
Aurinia Pharmaceuticals Inc. has completed 7 funding rounds, raising a total of $658.63M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Aurinia Pharmaceuticals Inc. include Fresno Unified School District, First State Bank of St. Charles, Ninth Circuit Court of Florida , Engility Corporation Formerly TASC, Naval Sea Systems Command (NAVSEA). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aurinia Pharmaceuticals Inc. and Fresno Unified School District are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aurinia Pharmaceuticals Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy